According to the recent study the global stent market is projected to reach an estimated $24 billion by 2030 from $17 billion in 2023 at a CAGR of 5.2% from 2023 to 2030. Growth in this market is primarily driven by increasing interventional cardiology and peripheral vascular procedures and rising adoption of technological advancements in an effort to reduce treatment duration for high risk conventional surgical patients.
A more than150 pages report
to understand trends, opportunities and forecast in global stent market by product
type (coronary stent and peripheral vascular stent), material (metal and
polymer), technology (bare metal stent, drug eluting stent, and bioreabsorbable
stent), end use (hospital and ambulatory surgical center), and region (North
America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that
the coronary stent segment will show above average growth during the forecast
period due to increasing cases of cardiovascular disorders.
Within the global stent
market, the drug eluting stent segment will remain the largest market by
technology during the forecast period due to low restenosis rate after surgery.
Bioreabsorbable stent is expected to witness the highest growth during the
forecast period due to its property of getting absorbed in the body.
North America is
expected to remain the largest market during the forecast period mainly due to
its well-developed healthcare infrastructure and continued technological
advancements across the healthcare industry.
Abbott Laboratory,
Boston Scientific, Medtronic public limited company, C R Bard, Cook Medical
Inc., Terumo Corporation, and Cardinal Health are among the major stent
providers.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
No comments:
Post a Comment